Recent NVCR Stock Price | NVCR Stock Predictions | |
$18.10 | +46.80% |
$26.57 |
Recent NVCR Analyst Ratings Breakdown, Making NVCR Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 3 | 4 | 4 | 4 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.86 | 2.14 | 2.14 | 2.14 |
For the NVCR stock predictions from the analysts covering NovoCure Ltd, we have collected all of the individual NVCR stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 7 different analysts covering NVCR (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NVCR stock predictions may vary widely, another useful metric to consider is the median NVCR stock prediction, which represents the price at which half of the analysts
made NVCR stock predictions that were higher and half made NVCR stock predictions that were lower. This makes for a different take on the NVCR stock predictions out there, as compared to average or mean.
And that median across all the individual NVCR stock predictions was: $28.0 as of 2024-11-01.
The very highest of the NVCR stock predictions for one year price target was $40.0, while the very lowest of the NVCR stock predictions in the analyst group was
$18.0 (with a standard deviation of $7.634). Get the latest Zacks research report on NVCR — FREE
Find out: NVCR next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
BBL Stock Predictions
HFWA Stock Predictions
MLM Stock Predictions
SAFM Stock Predictions
INOV Stock Predictions
GAIA Stock Predictions
GFED Stock Predictions
VFC Stock Predictions
TNAV Stock Predictions
|
|
Buy (3.14 out of 4) 42nd percentile
(ranked lower than approx. 58% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |